← Eichor
Study identifier: NCT04570020 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Scleral Lens Fitting Using Wide-Field OCT

Condition: Keratoconus · Irregular; Contour of Cornea  ·  Sponsor: Oregon Health and Science University

PhaseN/A
Planned participants258
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to see if OCT technology can optimize scleral contact lens fittings. Subjects with keratoconus, post-penetrating keratoplasty (PK), post-LASIK ectasia, post-radial keratotomy (RK), or a variety of anterior surface disorders requiring scleral lens fittings will be considered for enrollment. For each study eye, a clinically-selected scleral lens fit will be compared against an OCT-selected lens fit. The quality of each lens fit will be determined by flourescein exam at the slit lamp. Apical clearance, limbal clearance, conjunctival compression, and lens edge lift will be assessed. A lens that satisfies all four criteria will be considered satisfactory.

This description comes directly from the study's public registry record.

Talk to the study team

Humberto Martinez, COT  ·  503-494-7712  ·  martinhu@ohsu.edu

Denzil Romfh, OD  ·  503-494-4351  ·  romfhd@ohsu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Oregon Health & Science University, Casey Eye InstitutePortland, Oregon, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04570020